Aggression in autism spectrum disorder: presentation and treatment options

被引:150
作者
Fitzpatrick, Sarah E. [1 ]
Srivorakiat, Laura [1 ]
Wink, Logan K. [1 ]
Pedapati, Ernest V. [1 ]
Erickson, Craig A. [1 ]
机构
[1] Univ Cincinnati, Coll Med, Cincinnati Childrens Hosp Med Ctr, 3333 Burnet Ave, Cincinnati, OH 45229 USA
关键词
autism; autism spectrum disorder; aggression; treatment; antipsychotics; applied behavior analysis; PERVASIVE DEVELOPMENTAL DISORDERS; PLACEBO-CONTROLLED TRIAL; RAPID CLOZAPINE TITRATION; CONTROLLED CLINICAL-TRIAL; OF-THE-LITERATURE; DOUBLE-BLIND; OPEN-LABEL; INTELLECTUAL DISABILITIES; FUNCTIONAL-ANALYSIS; BEHAVIOR PROBLEMS;
D O I
10.2147/NDT.S84585
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by persistent difficulties in social communication and social interaction, coupled with restricted, repetitive patterns of behavior or interest. Research indicates that aggression rates may be higher in individuals with ASD compared to those with other developmental disabilities. Aggression is associated with negative outcomes for children with ASD and their caregivers, including decreased quality of life, increased stress levels, and reduced availability of educational and social support. Therapeutic strategies including functional behavioral assessment, reinforcement strategies, and functional communication training may have a significant impact in reducing the frequency and intensity of aggressive behavior in individuals with ASD. Pharmacologic treatments, particularly the use of second-generation antipsychotics, may also be of some benefit in reducing aggression in individuals with ASD. With the ever-increasing rate of ASD diagnosis, development of effective therapeutic and pharmacologic methods for preventing and treating aggression are essential to improving outcomes in this disorder.
引用
收藏
页码:1525 / 1538
页数:14
相关论文
共 131 条
[1]   Drug-refractory aggression, self-injurious behavior, and severe tantrums in autism spectrum disorders: A chart review study [J].
Adler, Benjamin A. ;
Wink, Logan K. ;
Early, Maureen ;
Shaffer, Rebecca ;
Minshawi, Noha ;
McDougle, Christopher J. ;
Erickson, Craig A. .
AUTISM, 2015, 19 (01) :102-106
[2]  
Aman MG, 1986, Aberrant behavior checklist manual
[3]   Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial [J].
Aman, Michael ;
Rettiganti, Mallikarjuna ;
Nagaraja, Haikady N. ;
Hollway, Jill A. ;
McCracken, James ;
McDougle, Christopher J. ;
Tierney, Elaine ;
Scahill, Lawrence ;
Arnold, L. Eugene ;
Hellings, Jessica ;
Posey, David J. ;
Swiezy, Naomi B. ;
Ghuman, Jaswinder ;
Grados, Marco ;
Shah, Bhavik ;
Vitiello, Benedetto .
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2015, 25 (06) :482-493
[4]  
American Psychiatric Association, 2003, DIAGN STAT MAN MENT
[5]   THE EFFECTS OF HALOPERIDOL ON DISCRIMINATION-LEARNING AND BEHAVIORAL SYMPTOMS IN AUTISTIC-CHILDREN [J].
ANDERSON, LT ;
CAMPBELL, M ;
ADAMS, P ;
SMALL, AM ;
PERRY, R ;
SHELL, J .
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 1989, 19 (02) :227-239
[6]  
[Anonymous], 2004, MONOGR SOC RES CHILD, V69, pvii
[7]  
[Anonymous], COCHRANE DATABASE SY
[8]  
ARMENTEROS JL, 1995, PSYCHOPHARMACOL BULL, V31, P363
[9]   A comparison of methodologies of brief functional analysis [J].
Badgett, Natalie ;
Falcomata, Terry S. .
DEVELOPMENTAL NEUROREHABILITATION, 2015, 18 (04) :224-233
[10]   Retrospective Review of Clozapine in the Treatment of Patients With Autism Spectrum Disorder and Severe Disruptive Behaviors [J].
Beherec, Laurene ;
Lambrey, Simon ;
Quilici, Gwendoline ;
Rosier, Antoine ;
Falissard, Bruno ;
Guillin, Olivier .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 31 (03) :341-344